台股 » 個股 » 中裕 » 籌碼相關 » 融資融券與借券

中裕

(4147)
可現股當沖
  • 股價
    79.9
  • 漲跌
    ▲0.2
  • 漲幅
    +0.25%
  • 成交量
    287
  • 產業
    上櫃 生技醫療類股
  • 315人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
中裕 (4147) 融資融券與借券

股票投資新手教室: 一分鐘搞懂「融資融券」

中裕 (4147) 融資融券與借券

中裕 (4147) 近三十日融資融券與借券賣出
日期 融資 融券 資券互抵(張) 資券當沖(%) 券資比(%) 價格 比例 成交量
增加 餘額 使用率% 增加 餘額 使用率%
11/22-46,3569.310290.0420.70.4679.90.25%287
11/21-86,3609.320290.04000.4679.70.89%167
11/2076,3689.331290.04000.46790.51%209
11/1936,3619.321280.04000.4478.6-0.13%195
11/18-266,3589.31-6270.04000.4278.7-2.24%412
11/15-226,3849.350330.05000.5280.5-0.62%270
11/14-106,4069.38-5330.05000.5281-0.86%332
11/1396,4169.4-1380.06000.5981.7-0.97%714
11/12-126,4079.380390.06000.6182.50.12%553
11/11-1306,4199.41390.06000.6182.42.87%1,040
11/08336,5499.59-1380.06000.5880.1-1.84%595
11/07-356,5169.54-2390.06000.681.60.99%379
11/0606,5519.6-1410.0610.270.6380.8-0.98%366
11/05-206,5519.6-1420.0610.440.6481.60.00%226
11/04-46,5719.630430.0610.320.6581.6-1.45%313
11/01-476,5759.636430.0610.160.6582.81.72%636
10/30-956,6229.72370.0510.090.5681.40.62%1,116
10/29-166,7179.840350.05000.5280.9-0.12%489
10/28226,7339.865350.0520.150.5281-0.49%1,359
10/25-466,7119.830300.04000.4581.40.74%552
10/24-226,7579.9-1300.0410.140.4480.8-1.22%711
10/23-356,7799.93-8310.05000.4681.81.49%985
10/22-626,8149.9816390.0620.10.5780.67.32%2,044
10/21-406,87610.071230.03000.3375.12.04%265
10/18196,91610.130220.03000.3273.6-1.87%324
10/1706,89710.10220.03000.32751.08%183
10/16-366,89710.10220.03000.3274.20.00%167
10/15-306,93310.160220.03000.3274.20.27%193
10/14-826,96310.20220.03000.3274-0.94%263
10/11-57,04510.320220.03000.3174.71.08%249
日期 融券 借券賣出 價格 比例 成交量
買進 賣出 增加 餘額 使用率% 賣出 還券 調整 增加 餘額
11/22000029@Limit20.041514015,96679.90.25%287
11/21000029@Limit20.04129035,96579.70.89%167
11/20010129@Limit20.041514015,962790.51%209
11/19120128@Limit20.0426540-285,96178.6-0.13%195
11/18600-627@Limit20.0467960-295,98978.7-2.24%412
11/15000033@Limit20.057660-596,01880.5-0.62%270
11/14500-533@Limit20.05291330-1046,07781-0.86%332
11/13100-138@Limit20.068550-476,18181.7-0.97%714
11/12000039@Limit20.0619310-126,22882.50.12%553
11/11010139@Limit20.066650-596,24082.42.87%1,040
11/08100-138@Limit20.069100-16,29980.1-1.84%595
11/07200-239@Limit20.068500-426,30081.60.99%379
11/06100-141@Limit20.0621100116,34280.8-0.98%366
11/05100-142@Limit20.0611750-646,33181.60.00%226
11/04330043@Limit20.0633380-56,39581.6-1.45%313
11/01060643@Limit20.0626750-496,40082.81.72%636
10/30020237@Limit20.0582420406,44981.40.62%1,116
10/29000035@Limit20.051400146,40980.9-0.12%489
10/28050535@Limit20.058073076,39581-0.49%1,359
10/25000030@Limit20.041716016,38881.40.74%552
10/24100-130@Limit20.04462100-1646,38780.8-1.22%711
10/23800-831@Limit20.052920096,55181.81.49%985
10/2221801639@Limit20.06108400686,54280.67.32%2,044
10/21120123@Limit20.0311170-66,47475.12.04%265
10/18000022@Limit20.0380810-16,48073.6-1.87%324
10/17000022@Limit20.032200226,481751.08%183
10/16000022@Limit20.034900496,45974.20.00%167
10/15000022@Limit20.031800186,41074.20.27%193
10/14000022@Limit20.035100516,39274-0.94%263
10/11000022@Limit20.036600666,34174.71.08%249
日期 當沖成交張數 買進成交金額 賣出成交金額 現股當沖率(%) 平均盈虧
11/22534,259,4004,263,60018.4779.25
11/21282,218,8002,221,50016.7796.43
11/20312,442,3002,454,40014.83390.32
11/19463,609,0003,616,00023.59152.17
11/18846,645,1006,660,70020.39185.71
11/15544,367,2004,369,3002038.89
11/14614,960,2004,960,90018.3711.48
11/1314111,553,40011,558,10019.7533.33
11/1212910,623,40010,607,30023.33-124.81
11/1116613,361,30013,563,70015.961219.28
11/081139,111,3009,117,40018.9953.98
11/07564,573,1004,582,10014.78160.71
11/06473,818,4003,828,90012.84223.4
11/05403,267,6003,271,00017.785
11/04473,868,3003,872,80015.0295.74
11/0113811,332,00011,357,30021.7183.33
10/3044136,484,60036,554,60039.52158.73
10/2914311,508,30011,511,10029.2419.58
10/2860149,950,50049,846,90044.22-172.38
10/251189,644,6009,640,80021.38-32.2
10/2422818,537,00018,541,10032.0717.98
10/2330424,747,00024,768,60030.8671.05
10/2259646,982,30047,401,70029.16703.69
10/21221,639,0001,647,8008.3400
10/1811820,500811,4003.4-827.27
10/1713978,100976,0007.1-161.54
10/16181,341,6001,343,10010.7883.33
10/15392,905,2002,908,20020.2176.92
10/14402,969,8002,986,30015.21412.5
10/11413,065,0003,060,00016.47-121.95
中裕長效型愛滋療法2a臨床全數完成注射 今年底至明年初可獲初步結果Anue鉅亨-2024/08/30
中裕與沙國藥廠簽抗愛滋病新藥中東、北非獨家銷售合約UDN聯合新聞網-2024/03/14
中裕 相關文章